Jan 30 (Reuters) - Mallinckrodt Plc:
* FIRST PATIENT ENROLLED IN MALLINCKRODT PHASE 4 TRIAL OF H.P. ACTHARÂ® GEL (REPOSITORY CORTICOTROPIN INJECTION) FOR PULMONARY SARCOIDOSIS Source text for Eikon: Further company coverage:
 